Finance News – Verve Therapeutics
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Investors
Stock
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Xrp
Eth
Bse
Etf
Earnings
Stablecoin
Ipo
Investment
Blockchain
Index
Revenue
Solana
Trade
Sec
Interest Rates
Inflation
Token
Wall Street
Sensex
Coinbase
Treasury
Federal Reserve
Nasdaq
Traders
Nse
Profit
Bse Sensex
China
Nifty
Sp 500
Gold
Investor
Tesla
Company
Defi
Money
Outflows
Economic Strategy
Euler
Woo X
Biosig Technologies
Headwinds
Secunet Security Networks Ag
Childcare Costs
Participants
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Investopedia • Jun 17, 2025
Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B
Eli Lilly's $1.3 billion acquisition of a gene-editing company has led to a notable increase in Verve Therapeutics' share value, reflecting investor optimism about potential financ...
Read Full Article →